AI could spot sepsis before It's too late
NCT ID NCT07543497
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new AI tool called Sepsis ImmunoScore that helps doctors quickly identify patients at risk of sepsis. Researchers will enroll 5,000 adults in U.S. hospitals to see if the tool improves diagnosis and speeds up treatment. The goal is to reduce serious complications and save lives.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Sepsis ImmunoScore (AI-based diagnostic test)
What this could lead to
If successful, this AI tool could help doctors spot sepsis earlier, leading to faster treatment and better survival.
What could go wrong
This is an early-stage device study, not a treatment trial. The tool may not improve outcomes in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••